CXCL10 - C-X-C motif chemokine ligand 10 Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 101100131
CXCL10 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_003985274.4 | XP_003985323.3 | C-X-C motif chemokine 10 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
C-X-C motif chemokine 10 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0426A | Olopatadine hydrochloride | 99.83% | Unkown | |
| HY-W062109 | Olopatadine | 98.94% | Unkown | |
| HY-B0426AR | Olopatadine hydrochloride (Standard) | / | Unkown |
Clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-148511 | Vidutolimod | 93.85% | Phase 3 |
Inhibitory Antibodies
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99190 | Eldelumab | Inhibitor | 99.50% | Phase 2 |
| HY-P990639 | NI-0801 | 99.19% | Phase 2 | |
| HY-P991582 | BI-1607 | / | Phase 2 | |
| HY-P992047 | BMS-986184 | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(45)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-15319 | AMG 487 | Inhibitor | 99.89% | Unkown |
| HY-15589 | GW9508 | 99.23% | Unkown | |
| HY-152237 | TBK1-IN-1 | Inhibitor | 99.63% | Unkown |
| HY-15320 | NBI-74330 | Antagonist | 99.76% | Unkown |
| HY-124151 | Adenosine-2'-monophosphate | Activator | 99.91% | Unkown |
| HY-111149A | PS372424 hydrochloride | Agonist | ≥98.0% | Unkown |
| HY-122891 | SB02024 | 99.70% | Unkown | |
| HY-152956 | STING agonist-23 | Agonist | 99.33% | Unkown |
| HY-N7688 | Regaloside B | Inhibitor | 99.90% | Unkown |
| HY-165428 | SCH-900875 | Inhibitor | 98.16% | Unkown |
| HY-152959 | STING agonist-26 | Agonist | 99.56% | Unkown |
| HY-162675 | COB-187 | Inhibitor | 95.0% | Unkown |
| HY-183058 | EZM8266 | Inhibitor | 98.24% | Unkown |
| HY-164919 | Calotatug ginistinag | 95.94% | Unkown | |
| HY-181654 | Snail IN-1 | Inhibitor | 98.27% | Unkown |
| HY-111149 | PS372424 | Agonist | / | Unkown |
| HY-RS03384 | CXCL10 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-15589R | GW9508 (Standard) | 98.07% | Unkown | |
| HY-113730 | VUF5834 | Antagonist | / | Unkown |
| HY-147129 | cGAS-IN-9 | Inhibitor | / | Unkown |
| HY-152957 | STING agonist-24 | Agonist | / | Unkown |
| HY-152958 | STING agonist-25 | Agonist | / | Unkown |
| HY-152961 | STING agonist-28 | Agonist | / | Unkown |
| HY-15319A | (±)-AMG 487 | Inhibitor | / | Unkown |
| HY-158036 | PROTAC STING Degrader-2 | / | Unkown | |
| HY-168554 | STING Degrader-3 | / | Unkown | |
| HY-173404 | VB-85247 | / | Unkown | |
| HY-174136 | STING Degrader-2 | / | Unkown | |
| HY-176257 | STING agonist-44 | Agonist | / | Unkown |
| HY-178032 | PARP1-IN-44 | / | Unkown | |
| HY-179288 | TPST2-IN-1 | Inhibitor | / | Unkown |
| HY-181484 | STING agonist-50 | / | Unkown | |
| HY-181877 | IHCH-3185 | / | Unkown | |
| HY-182926 | Topoisomerase I/II-IN-9 | Inhibitor | / | Unkown |
| HY-183325 | FTO-IN-17 | Inhibitor | / | Unkown |
| HY-183607 | SMU-3k | / | Unkown | |
| HY-184500 | TNG917 | Inhibitor | / | Unkown |
| HY-B0426AS2 | Olopatadine-d6 hydrochloride | / | Unkown | |
| HY-W062109S | Olopatadine-d6 | / | Unkown | |
| HY-W104821 | Rosolic acid | Activator | / | Unkown |
| HY-167884 | PF-1367550 | Inhibitor | / | Unkown |
| HY-172167 | PD-L1/HDAC-IN-1 | Inhibitor | / | Unkown |
| HY-B0426AS | Olopatadine-d3 hydrochloride | / | Unkown | |
| HY-RS16518 | Cxcl10 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22949 | Cxcl10 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Inhibitory Antibodies
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991761 | Anti-Mouse CXCL10 Antibody (1F11) | Inhibitor | 97.564% | Unkown |
| HY-P991208 | Flt-3L-Ig (hum/hum) | 98% | Unkown | |
| HY-P991989 | MRG004A Antibody | 95.44% | Unkown |